Skip to content

Innoviva, Inc. INVA Shares (Diluted)

Shares (Diluted) at other companies

Pfizer logo
PfizerPFE
5.7B+0.4%
AbbVie logo
AbbVieABBV
1.8B+0.1%
Insmed logo
InsmedINSM
215.5M+19.1%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
164.9M+3.9%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
45.1M+32.9%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
19.9M+3.6%

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s shares (diluted)?
Innoviva, Inc. (INVA) reported shares (diluted) of 84.8M in Q1 2026.
How has Innoviva, Inc.'s shares (diluted) changed year-over-year?
Innoviva, Inc.'s shares (diluted) increased by 35.3% year-over-year, from 62.7M to 84.8M.
What is the long-term trend for Innoviva, Inc.'s shares (diluted)?
Over 4 years (2021 to 2025), Innoviva, Inc.'s shares (diluted) has grown at a -5.1% compound annual growth rate (CAGR), from 390.3M to 316.9M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.